Xelari
Xelari Inc. is a biotechnology company developing a revolutionary AI-powered platform for designing functional molecular binders called XELAMERs, based on DNA and RNA. Their platform enables precise, programmable molecular tools that outperform traditional protein binders by leveraging DNA's stability, programmability, and modifiability. The company targets industries including diagnostics, therapy, manufacturing, veterinary, agriculture, and environmental science. Xelari offers a subscription-based SaaS platform with tiered pricing for academic and commercial users, providing early access and pilot projects to accelerate innovation in molecular tool development. Their technology aims to transform molecular binding processes with high precision and versatility, positioning them as a pioneer in next-generation biotechnology tools.
Xelari
Xelari Inc. is a biotechnology company developing a revolutionary AI-powered platform for designing functional molecular binders called XELAMERs, based on DNA and RNA. Their platform enables precise, programmable molecular tools that outperform traditional protein binders by leveraging DNA's stability, programmability, and modifiability. The company targets industries including diagnostics, therapy, manufacturing, veterinary, agriculture, and environmental science. Xelari offers a subscription-based SaaS platform with tiered pricing for academic and commercial users, providing early access and pilot projects to accelerate innovation in molecular tool development. Their technology aims to transform molecular binding processes with high precision and versatility, positioning them as a pioneer in next-generation biotechnology tools.